CN101175732B - 一种喹唑啉衍生物的制备方法及用作制备治疗肿瘤疾病药物的应用 - Google Patents
一种喹唑啉衍生物的制备方法及用作制备治疗肿瘤疾病药物的应用 Download PDFInfo
- Publication number
- CN101175732B CN101175732B CN2005800497598A CN200580049759A CN101175732B CN 101175732 B CN101175732 B CN 101175732B CN 2005800497598 A CN2005800497598 A CN 2005800497598A CN 200580049759 A CN200580049759 A CN 200580049759A CN 101175732 B CN101175732 B CN 101175732B
- Authority
- CN
- China
- Prior art keywords
- alkyl
- methyl
- salt
- compound
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (21)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2005/000660 WO2006119673A1 (fr) | 2005-05-12 | 2005-05-12 | Procede de preparation de derives de quinazoline et application pour la fabrication pour le traitement d’une maladie tumorale |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101175732A CN101175732A (zh) | 2008-05-07 |
CN101175732B true CN101175732B (zh) | 2010-06-16 |
Family
ID=37396179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800497598A Active CN101175732B (zh) | 2005-05-12 | 2005-05-12 | 一种喹唑啉衍生物的制备方法及用作制备治疗肿瘤疾病药物的应用 |
Country Status (3)
Country | Link |
---|---|
US (1) | US7825245B2 (zh) |
CN (1) | CN101175732B (zh) |
WO (1) | WO2006119673A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014224382B2 (en) | 2013-03-06 | 2016-11-10 | Astrazeneca Ab | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1211239A (zh) * | 1996-02-13 | 1999-03-17 | 曾尼卡有限公司 | 作为vegf抑制剂的喹唑啉衍生物 |
CN1231662A (zh) * | 1996-09-25 | 1999-10-13 | 曾尼卡有限公司 | 喹唑啉衍生物和含有喹唑啉衍生物的药用组合物 |
CN1542004A (zh) * | 2003-04-30 | 2004-11-03 | 黄文林 | 一种酪氨酸激酶抑制剂及其制备方法和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9314893D0 (en) * | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
US6375213B1 (en) | 1999-09-27 | 2002-04-23 | Combi Corporation | Stroller |
CN1211239C (zh) | 2001-07-23 | 2005-07-20 | 好孩子儿童用品有限公司 | 童车 |
CN1231662C (zh) | 2002-09-27 | 2005-12-14 | 中国科学院山西煤炭化学研究所 | 车载甲醇催化裂解装置的油路自动控制系统 |
-
2005
- 2005-05-12 CN CN2005800497598A patent/CN101175732B/zh active Active
- 2005-05-12 WO PCT/CN2005/000660 patent/WO2006119673A1/zh active Application Filing
-
2007
- 2007-11-13 US US11/939,265 patent/US7825245B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1211239A (zh) * | 1996-02-13 | 1999-03-17 | 曾尼卡有限公司 | 作为vegf抑制剂的喹唑啉衍生物 |
CN1231662A (zh) * | 1996-09-25 | 1999-10-13 | 曾尼卡有限公司 | 喹唑啉衍生物和含有喹唑啉衍生物的药用组合物 |
CN1542004A (zh) * | 2003-04-30 | 2004-11-03 | 黄文林 | 一种酪氨酸激酶抑制剂及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2006119673A1 (fr) | 2006-11-16 |
US20080167328A1 (en) | 2008-07-10 |
CN101175732A (zh) | 2008-05-07 |
US7825245B2 (en) | 2010-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103930425B (zh) | 蝶啶酮衍生物及其作为egfr、blk、flt3抑制剂的应用 | |
EP1678166B1 (en) | Protein kinase inhibitors | |
EP0824525B1 (en) | Quinazoline derivatives | |
EP0824526B1 (en) | Quinazoline derivative | |
CN105408334B (zh) | 作为激酶抑制剂的取代的吡唑并嘧啶类化合物 | |
US20100029673A1 (en) | Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use | |
US20080051414A1 (en) | Protein Kinase Inhibitors | |
CN102838550B (zh) | 喹唑啉巴豆基化合物及其在制备抗恶性肿瘤药物中的用途 | |
JP2000505441A (ja) | キナゾリン化合物 | |
CN103370314A (zh) | 作为用于治疗癌症疾病的fgfr激酶抑制剂的取代苯并吡嗪衍生物 | |
CN101896227A (zh) | 包含mek抑制剂和极光激酶抑制剂的组合 | |
CN105980377B (zh) | 作为egfr-t790m激酶抑制剂的取代的嘧啶类化合物 | |
CN114920704B (zh) | 一种苯基哌嗪喹唑啉类化合物或其药学上可接受的盐、制法与用途 | |
CN101175732B (zh) | 一种喹唑啉衍生物的制备方法及用作制备治疗肿瘤疾病药物的应用 | |
CN101175734B (zh) | 一种作为抗肿瘤药物的喹唑啉衍生物及其制备方法 | |
CN103965119A (zh) | 含有锌结合基的不可逆egfr酪氨酸激酶抑制剂 | |
CN1542004A (zh) | 一种酪氨酸激酶抑制剂及其制备方法和用途 | |
CN101696183B (zh) | (z)-2-苯基-3-(吡咯-2-基)-丙烯腈衍生物及其盐、组合物以及制备方法和用途 | |
CN108117551A (zh) | 取代(1H-吡唑[3,4-b]吡啶)脲类化合物及其抗肿瘤用途 | |
WO2006119675A1 (fr) | Procede de preparation de derives de quinazoline et application pour la fabrication pour le traitement d'une maladie tumorale | |
WO2006119674A1 (fr) | Procede de preparation de derives de quinazoline et application pour la fabrication pour le traitement d’une maladie tumorale | |
CN107417565B (zh) | 作用于fgfr1的4-溴-n-3,5-二甲氧基苯基苯甲酰胺衍生物及其制备和应用 | |
CN103202843A (zh) | 一种嘧啶衍生物在制备预防和/或治疗和/或辅助治疗癌症的药物中的用途 | |
CN111840299A (zh) | 一种喹啉类化合物在制备治疗癌症药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Guangzhou doublink Biological Products Co. Assignor: Zhou Xiaohong|Huang Wenlin Contract record no.: 2011990000310 Denomination of invention: Production method for quinazoline derivatives and its application for producing medicine used for treating tumor disease Granted publication date: 20100616 License type: Exclusive License Open date: 20080507 Record date: 20110425 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160601 Address after: 510663 A room 209, international business incubator, Luogang District Science City, Guangzhou, Guangdong Patentee after: Guangzhou doublink Biological Products Co. Address before: 510663 A Room 201, international business incubator, Luogang District Science City, Guangzhou, Guangdong Patentee before: Guangzhou new Thai Biotechnology Co.,Ltd. Effective date of registration: 20160601 Address after: 510663 A Room 201, international business incubator, Luogang District Science City, Guangzhou, Guangdong Patentee after: Guangzhou new Thai Biotechnology Co.,Ltd. Address before: Room 209-210, Guangzhou international business incubator, Guangzhou Science City, Guangdong, China Patentee before: Huang Wenlin Patentee before: Zhou Xiaohong |